Literature DB >> 14652690

Sacral inflammatory pseudotumor revealed by paraneoplastic syndrome.

Y Allanore1, X V Pham, D A Clerc, C J Menkès, A Kahan.   

Abstract

There is still debate on whether inflammatory pseudotumor should be considered benign or malignant. This lesion has only been reported twice in bone, apart from cases complicating foreign body reaction to joint replacement arthroplasty. We report here a third case, localized at the sacrum. A 31-year-old man had inflammatory dorsalgia and polyarthralgia without synovitis but with fever, asthenia, and erythema nodosa. Biological tests and X-rays were not informative, but technetium scintigraphy revealed a high level of left sacroiliac tracer binding. Several nonsteroidal anti-inflammatory drugs and sulfasalazine treatment were given over 3 months but ineffective. Pelvic magnetic resonance imaging showed an osteolytic tumor of the sacrum. Biopsy suggested a malignant fibrosarcoma, but complete evaluation after surgical resection demonstrated an inflammatory pseudotumor. All clinical symptoms disappeared within a few days after surgery, which is suggestive of a paraneoplastic syndrome. No relapse has occurred after 4 years.

Entities:  

Mesh:

Year:  2003        PMID: 14652690     DOI: 10.1007/s00296-003-0365-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

Review 1.  Inflammatory pseudotumor: a controversial entity.

Authors:  J Dahabreh; C Zisis; N Arnogiannaki; K Katis; D Jubrail; Z Charalambos; A Niki; K Konstantinos
Journal:  Eur J Cardiothorac Surg       Date:  1999-12       Impact factor: 4.191

2.  Massive pelvic and femoral pseudotumoral osteolysis secondary to an uncemented total hip arthroplasty.

Authors:  C Jeanrot; M Ouaknine; P Anract; M Forest; B Tomeno
Journal:  Int Orthop       Date:  1999       Impact factor: 3.075

3.  Aggressive inflammatory pseudotumor of the abdomen 9 years after therapy for Wilms tumor. A complication, coincidence, or association?

Authors:  G M Vujanić; D Milovanović; S Aleksandrović
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

4.  Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences.

Authors:  L R Donner; R A Trompler; R R White
Journal:  Hum Pathol       Date:  1996-10       Impact factor: 3.466

5.  Prognostic factors in pulmonary fibrohistiocytic lesions.

Authors:  A A Gal; M N Koss; W F McCarthy; L Hochholzer
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

Review 6.  Inflammatory pseudotumors of the lung.

Authors:  R S Berardi; S S Lee; H P Chen; G J Stines
Journal:  Surg Gynecol Obstet       Date:  1983-01

7.  Plasma cell granuloma of the stomach. A report of a case associated with gastric cancer.

Authors:  T Tada; T Wakabayashi; H Kishimoto
Journal:  Cancer       Date:  1984-08-01       Impact factor: 6.860

8.  Inflammatory myofibroblastic tumor of bone: report of two cases with evidence of clonal chromosomal changes.

Authors:  R Sciot; P Dal Cin; C D Fletcher; J M Hernandez; J L Garcia; I Samson; L Ramos; P Brys; B Van Damme; H Van den Berghe
Journal:  Am J Surg Pathol       Date:  1997-10       Impact factor: 6.394

9.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

10.  Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases.

Authors:  R Biselli; C Ferlini; A Fattorossi; R Boldrini; C Bosman
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

  10 in total
  2 in total

1.  Inflammatory myofibroblastic tumor of bone: two cases occurring in long bone.

Authors:  Jianyu Chen; Haigang Li; Zehong Yang; Qingyu Liu; Ming Gao; Xinhua Jiang; Zhaoxi Cai; Biling Liang; Yebin Jiang
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

2.  Cross-segment spinal plasma cell granuloma:a case report.

Authors:  Renqin Lin; Shenglin Wang; Jianhua Lin; Zhenzhen Zhang; Xuanwei Chen
Journal:  BMC Musculoskelet Disord       Date:  2020-11-12       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.